SomaBeats Health offers a neuroscience‑backed digital therapeutic that runs on an Apple Watch and automatically delivers adaptive haptic pulses to calm users when physiological sensors detect a stress spike. Using real‑time biometric sensing and closed‑loop machine learning, the system provides zero‑interruption, personalized anxiety relief without requiring any active effort from the wearer.
Funding
Funding not disclosed
Founders
Product
Problem
Many adults experience acute anxiety that interferes with focus and performance, yet existing interventions require active effort such as breathing exercises or taking breaks, which are impractical during work, driving, or meetings.
Solution
SomaBeats delivers a neuroscience‑backed wearable that runs on an Apple Watch and automatically emits adaptive haptic pulses when physiological sensors detect a stress spike. Machine‑learning algorithms analyze heart‑rate and other signals in real time to trigger neuromodulation without user input. The haptic feedback communicates directly with the nervous system, helping the body self‑regulate and reducing in‑the‑moment anxiety by up to 30 % in clinical studies. Because the intervention is passive and zero‑interruption, users can maintain focus while continuing their activities. The system continuously recalibrates to each individual’s physiological patterns, providing personalized relief without requiring conscious effort.
Target Audience
Primary users are high‑performing adults—professionals, students, and drivers—who need discreet, effort‑free anxiety management during demanding tasks.
Features
- Proprietary haptic neuromodulation integrated into the Apple Watch that delivers subtle, physiology‑tuned pulses
- Real‑time physiological sensing and closed‑loop machine‑learning model that detects stress spikes and triggers intervention automatically
- Zero‑interruption design that operates while users are speaking, driving, or in deep work, eliminating the need for active coping techniques
- Passive recalibration that adapts the pulse pattern to the user’s ongoing biometric trends for personalized effectiveness
- Clinical validation demonstrating a 30 % reduction in momentary anxiety and additional benefits for related behavioral outcomes